Biomarkers for glioblastoma multiforme: status quo

BACKGROUND: Glioblastoma (GBM) is the most frequent and most malignant central nervous system (CNS) tumor. GBM shows poor prognosis with a median overall survival of 14.6 months, despite current surgical and adjuvant therapies. O(6)-methylguanine-DNA methyltransferase (MGMT) methylation is the stron...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Transl Res
Main Authors: Montano, Nicola, D’Alessandris, Quintino Giorgio, Izzo, Alessandro, Fernandez, Eduardo, Pallini, Roberto
Format: Artigo
Sprog:Inglês
Udgivet: Whioce Publishing Pte. Ltd. 2016
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6410643/
https://ncbi.nlm.nih.gov/pubmed/30873456
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker